Business Context and Reporting Period
Company: Harvard Bioscience, Inc. (HBIO)
Filing Type: Form 8-K (Current Report)
Report Date: August 11, 2026
Reporting Period: The filing announces financial results for the three and six months ended June 30, 2026.
Key Financial Metrics
The provided text is a cover sheet and index for the Form 8-K. It references a press release (Exhibit 99.1) containing the actual financial data but does not list specific figures within this document.
- Revenue, Profit, Cash Flow, Margins: Not provided in this text; contained in the referenced press release.
- Debt and Liquidity: Not provided in this text; contained in the referenced press release.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus prior periods. It only confirms the issuance of results for the periods ended June 30, 2026.
Guidance, Outlook, and Management Commentary
Conference Call: Management scheduled a conference call for August 11, 2026, at 8:00 AM ET to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is furnished and not deemed "filed" under Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the three and six months ended June 30, 2026.
- Verify year-over-year growth rates and margin trends in the full press release.
- Check the conference call transcript (if available) for updated guidance and management commentary on the outlook.
- Confirm the status of the company's liquidity and debt obligations as detailed in the full financial statements referenced in the press release.